Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenge


5. Porters Five Forces

5.1 Competitive Rivalry
5.2 Supplier Power
5.3 Buyer Power
5.4 Threat of Substitution
5.5 Threat of New Entry


6. Global Prostate Cancer Diagnostic Market


7. Market Share – Global Prostate Cancer Diagnostic Analysis

7.1 By Test
7.2 By Test Type
7.3 By Region
7.4 By End User


8. Test – Global Prostate Cancer Diagnostic Market

8.1 Preliminary Test
8.2 Confirmatory Test


9. Test Type – Global Prostate Cancer Diagnostic Market

9.1 PSA3 TESR
9.2 Transrectal Ultrasound
9.3 Biopsy


10. Region – Global Prostate Cancer Diagnostic Market

10.1 North Europe

10.1.1 Total no. of Cases
10.1.2 Market

10.2 Western Europe

10.2.1 Total no. of Cases
10.2.2 Market

10.3 Carribean

10.3.1 Total no. of Cases
10.3.2 Market

10.4 Australia

10.4.1 Total no. of Cases
10.4.2 Market

10.5 North America

10.5.1 Total no. of Cases
10.5.2 Market

10.6 South Africa

10.6.1 Total no. of Cases
10.6.2 Market

10.7 South America

10.7.1 Total no. of Cases
10.7.2 Market

10.8 South Europe

10.8.1 Total no. of Cases
10.8.2 Market

10.9 Micronesia

10.10.1 Total no. of Cases
10.10.2 Market

10.10 Eastern Europe

10.10.1 Total no. of Cases
10.10.2 Market

10.11 Central America

10.12.1 Total no. of Cases
10.12.2 Market

10.12 Middle Africa

10.12.1 Total no. of Cases
10.12.2 Market

10.13 Melasnesia

10.13.1 Total no. of Cases
10.13.2 Market

10.14 Western Africa

10.14.1 Total no. of Cases
10.14.2 Market

10.15 Western Asia

10.15.1 Total no. of Cases
10.15.2 Market

10.16 Eastern Africa

10.16.1 Total no. of Cases
10.16.2 Market

10.17 Eastern Asia

10.17.1 Total no. of Cases
10.17.2 Market

10.18 North Africa

10.18.1 Total no. of Cases
10.18.2 Market

10.19 South East Asia

10.110.1 Total no. of Cases
10.110.2 Market

10.20 South Central Asia

10.20.1 Total no. of Cases
10.20.2 Market


11. End User – Global Prostate Cancer Diagnostic Market

11.1 Hospital and clinics
11.2 Diagnostic centers
11.3 Research Institutes
11.4 Others


12. Key Players Analysis

12.1 Thermo Fisher Scientific

12.1.1 Business Overview
12.1.2 Sales Analysis
12.1.3 Recent Development

12.2 Myriad Genetics, Inc.

12.2.1 Business Overview
12.2.2 Sales Analysis
12.2.3 Recent Development

12.3 Abbott Laboratories

12.3.1 Business Overview
12.3.2 Sales Analysis
12.3.3 Recent Development

12.4 F.Hoffman-La Roche AG

12.4.1 Business Overview
12.4.2 Sales Analysis
12.4.3 Recent Development

12.5 Siemens Healthineer AG

12.5.1 Business Overview
12.5.2 Sales Analysis
12.5.3 Recent Development

12.6 OPKO Health Inc.

12.6.1 Business Overview
12.6.2 Sales Analysis
12.6.3 Recent Development

12.7 Astra Zeneca

12.7.1 Business Overview
12.7.2 Sales Analysis
12.7.3 Recent Development

12.8 Bayer AG

12.8.1 Business Overview
12.8.2 Sales Analysis
12.8.3 Recent Development

12.9 Sanofi Avantis

12.9.1 Business Overview
12.9.2 Sales Analysis
12.9.3 Recent Development

12.10 Hologic Inc

12.10.1 Business Overview
12.10.2 Sales Analysis
12.10.3 Recent Development



List of Figures

Figure-01: Global – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-03: Type – Preliminary Test Market (Million US$), 2018 – 2022
Figure-04: Type – Forecast for Preliminary Test Market (Million US$), 2023 – 2028
Figure-05: Type – Confirmatory Test Market (Million US$), 2018 – 2022
Figure-06: Type – Forecast for Confirmatory Test Market (Million US$), 2023 – 2028
Figure-07: Test Type – PSA3 TESR Market (Million US$), 2018 – 2022
Figure-08: Test Type – Forecast for PSA3 TESR Market (Million US$), 2023 – 2028
Figure-09: Test Type – Transrectal Ultrasound Market (Million US$), 2018 – 2022
Figure-10: Test Type – Forecast for Transrectal Ultrasound Market (Million US$), 2023 – 2028
Figure-11: Test Type – Biopsy Market (Million US$), 2018 – 2022
Figure-12: Test Type – Forecast for Biopsy Market (Million US$), 2023 – 2028
Figure-13: North Europe – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-14: North Europe – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-15: North Europe – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-16: North Europe – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-17: Western Europe – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-18: Western Europe – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-19: Western Europe – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-20: Western Europe – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-21: Carribean – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-22: Carribean – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-23: Carribean – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-24: Carribean – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-25: Australia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-26: Australia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-27: Australia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-28: Australia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-29: North America – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-30: North America – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-31: North America – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-32: North America – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-33: South Africa – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-34: South Africa – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-35: South Africa – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-36: South Africa – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-37: South America – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-38: South America – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-39: South America – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-40: South America – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-41: South Europe – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-42: South Europe – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-43: South Europe – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-44: South Europe – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-45: Micronesia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-46: Micronesia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-47: Micronesia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-48: Micronesia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-49: Eastern Europe – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-50: Eastern Europe – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-51: Eastern Europe – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-52: Eastern Europe – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-53: Central America – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-54: Central America – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-55: Central America – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-56: Central America – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-57: Middle Africa – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-58: Middle Africa – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-59: Middle Africa – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-60: Middle Africa – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-61: Melasnesia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-62: Melasnesia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-63: Melasnesia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-64: Melasnesia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-65: Western Africa – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-66: Western Africa – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-67: Western Africa – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-68: Western Africa – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-69: Western Asia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-70: Western Asia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-71: Western Asia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-72: Western Asia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-73: Eastern Africa – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-74: Eastern Africa – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-75: Eastern Africa – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-76: Eastern Africa – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-77: Eastern Asia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-78: Eastern Asia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-79: Eastern Asia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-80: Eastern Asia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-81: North Africa – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-82: North Africa – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-83: North Africa – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-84: North Africa – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-85: South East Asia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-86: South East Asia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-87: South East Asia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-88: South East Asia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-89: South Central Asia – Prostate Cancer Diagnostic Volume (Total no. of Cases), 2018 – 2022
Figure-90: South Central Asia – Forecast for Prostate Cancer Diagnostic Volume (Total no. of Cases), 2023 – 2030
Figure-91: South Central Asia – Prostate Cancer Diagnostic Market (Billion US$), 2018 – 2022
Figure-92: South Central Asia – Forecast for Prostate Cancer Diagnostic Market (Billion US$), 2023 – 2028
Figure-93: End User – Hospital and clinics Market (Million US$), 2018 – 2022
Figure-94: End User – Forecast for Hospital and clinics Market (Million US$), 2023 – 2028
Figure-95: End User – Diagnostic centers Market (Million US$), 2018 – 2022
Figure-96: End User – Forecast for Diagnostic centers Market (Million US$), 2023 – 2028
Figure-97: End User – Research Institutes Market (Million US$), 2018 – 2022
Figure-98: End User – Forecast for Research Institutes Market (Million US$), 2023 – 2028
Figure-99: End User – Others Market (Million US$), 2018 – 2022
Figure-100: End User – Forecast for Others Market (Million US$), 2023 – 2028
Figure-101: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
Figure-102: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-103: Myriad Genetics, Inc. – Global Revenue (Billion US$), 2018 – 2022
Figure-104: Myriad Genetics, Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-105: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2022
Figure-106: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-107: F.Hoffman-La Roche AG – Global Revenue (Billion US$), 2018 – 2022
Figure-108: F.Hoffman-La Roche AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-109: Siemens Healthineer AG – Global Revenue (Billion US$), 2018 – 2022
Figure-110: Siemens Healthineer AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-111: OPKO Health Inc. – Global Revenue (Billion US$), 2018 – 2022
Figure-112: OPKO Health Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-113: Astra Zeneca – Global Revenue (Billion US$), 2018 – 2022
Figure-114: Astra Zeneca – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-115: Bayer AG – Global Revenue (Billion US$), 2018 – 2022
Figure-116: Bayer AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-117: SanofiAvantis – Global Revenue (Billion US$), 2018 – 2022
Figure-118: SanofiAvantis – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-119: Hologic Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-120: Hologic Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: Global – Prostate Cancer Diagnostic Market Share by Test (Percent), 2018 – 2022
Table-02: Global – Forecast for Prostate Cancer Diagnostic Market Share by Test (Percent), 2023 – 2028
Table-03: Global – Prostate Cancer Diagnostic Market Share by Test Type (Percent), 2018 – 2022
Table-04: Global – Forecast for Prostate Cancer Diagnostic Market Share by Test Type (Percent), 2023 – 2028
Table-05: Global – Prostate Cancer Diagnostic Market Share by Region (Percent), 2018 – 2022
Table-06: Global – Forecast for Prostate Cancer Diagnostic Market Share by Region (Percent), 2023 – 2028
Table-07: Global – Prostate Cancer Diagnostic Market Share by End User (Percent), 2018 – 2022
Table-08: Global – Forecast for Prostate Cancer Diagnostic Market Share by End User (Percent), 2023 – 2028